Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01067677

Rescue Emetic Therapy for Children Having Elective Surgery

Rescue Emetic Therapy for Children Having Elective Therapy

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Franklyn Cladis · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Accepted

Summary

To compare ondansetron, metoclopramide, diphenhydramine, and placebo in order to determine which anti-emetic is most efficacious as a "rescue therapy" for pediatric patients ages 3-18 who have post-operative vomiting after a standardized prophylactic regimen of ondansetron and dexamethasone. We hypothesize that anti-emetics with a different mechanism of action than the prophylactic regimen will be the most effective "rescue therapy" in children having surgery in an ambulatory surgery center. 1. Problem: Despite commonly-used anti-emetics for prophylaxis, some children still go on to develop post-operative vomiting (POV). Goal: To determine which anti-emetic--ondansetron, metoclopramide, diphenhydramine, or placebo--is most efficacious for pediatric patients in this situation. 2. Hypothesis: Anti-emetic medications that have a different mechanism of action than the prophylactic regimen will be the most efficacious "rescue therapy." 3. Hypothesis: Metoclopramide at the dose of 0.5 mg/kg (max dose 20 mg) will be more effective than ondansetron, diphenhydramine, or placebo as "rescue therapy."

Conditions

Interventions

TypeNameDescription
DRUGMetaclopramide0.5 mg/kg for rescue after PONV
DRUGOndansetron0.1 mg/kg (max 4 mg0
DRUGdiphenhydramine0.25 mg/kg (max 25 mg)
DRUGSalineequal volume (5 ml)as experimental rescue medications

Timeline

Start date
2010-02-01
Primary completion
2012-02-01
Completion
2014-02-01
First posted
2010-02-11
Last updated
2017-11-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01067677. Inclusion in this directory is not an endorsement.